THE POWER OF PROTEASOME INHIBITION

Welcome to the Brand page for “THE POWER OF PROTEASOME INHIBITION”, which is offered here for Prescription pharmaceutical preparations for use in the diagnosis or treatment of human diseases and disorders, circulatory, respiratory, endocrine, neurologic, cardiovascular, alimentary, oncologic, auto-immune or immune-related, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral urinary, renal, infectious, metabolic or central nervous system diagnostic assays and test kits consisting primarily of reagents for clinical, laboratory, medical and chemical use to diagnose, prognose, predict or treat diseases and for providing genomic and proteomic profiles useful in the selection of therapeutics; assays and test kits consisting primarily of reagents for evaluating efficacy of treatments and treatment progress; prognostic test kits consisting primarily of reagents for identifying hereditary risk factors; diagnostic preparations, preparations of extracts, assays, nucleic acids, proteins, polypeptides, and antibodies, and molecular arrays of biological materials for clinical or medical laboratory use;.

Its status is currently believed to be active. Its class is unavailable. “THE POWER OF PROTEASOME INHIBITION” is believed to be currently owned by “Millennium Pharmaceuticals, Inc.”